| Eric Vivier, Marco Colonna - 2005 - 209 páginas
...subjects. Diabetes 52:2639-2642 Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. (1992) Lymphoproliferation disorder in mice explained by...defects in Fas antigen that mediates apoptosis. Nature 356:314-317 Wiltrout RH, Mathieson BJ, Talmadge JE, Reynolds CW, Zhang SR, Herberman RB, Ortaldo JR.... | |
| 2006 - 392 páginas
...Immunol 164, 786-794. Watanabe-Fukunaga, R., Brannan, CI, Copeland, NG, Jenkins, NA, Nagata, S. (1992). Lymphoproliferation disorder in mice explained by...defects in Fas antigen that mediates apoptosis. Nature 356, 314-317. Watson, ML, Rao, JK, Gilkeson, OS, Ruiz, P., Eicher, EM, Pisetsky, DS, Matsuzawa, A.,... | |
| Kwang W. Jeon - 2006 - 280 páginas
...98, 47-58. Watanabe-Fukunaga, R., Brannan, C. L, Copeland, NG, Jenkins, NA, and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by...defects in Fas antigen that mediates apoptosis. Nature 356, 314-317. Watts, TH (2005). TNF/TNFR family members in costimulation of T cell responses. Annu.... | |
| Veronica D. Stolzt - 2006 - 200 páginas
...188:409-414. [50] Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferative Disorder In Mice Explained By Defects In Fas Antigen That Mediates Apoptosis. Nature 1992; 356:314-31 7. [51] Jenkins MA, Schwartz RH. Antigen Presentation By Chemically Modified Splenocytes... | |
| David A. Gewirtz, Shawn E. Holt, Steven Grant - 2007 - 599 páginas
...Nature 1993; 364(6440):798-802. 191. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by...defects in Fas antigen that mediates apoptosis. Nature 1992; 356(6367):314-7. 192. Yeh WC, Itie A, Elia AJ, et al. Requirement for Casper (c-FLIP) in regulation... | |
| George F. Vande Woude, George Klein - 2011 - 368 páginas
...258, 261-269. Watanabe-Fukunaga, R., Brannan, C. L, Copeland, NG, Jenkins, NA, and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by...defects in Fas antigen that mediates apoptosis. Nature 356, 314-317. Weissman, D., Rabin, RL, Arthos, J., Rubbert, A., Dybul, M., Swofford, R., Venkatesan,... | |
| Hans D. Ochs, C. I. Edward Smith, Jennifer M. Puck - 2006 - 776 páginas
...syndrome type II. Cell 98:47-58, 1999. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by...defects in Fas antigen that mediates apoptosis. Nature 356:314-318, 1992. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient... | |
| David Male, Jonathan Brostoff - 2007 - 624 páginas
...al. Tumor necrosis factor receptors and Fas signalling mechanisms. Annu Rev Immunol 1999;17:331-368. Watanabe-Fukunga R, Brannan CI, Copeland NG, et al....Lymphoproliferation disorder in mice explained by detects in Fas antigen that mediates apoptosis. Nature 1992;356:314. Yanelli JR, Sullivan JA, Mandell... | |
| Hong-wen Deng - 2007 - 963 páginas
...diabetes gene? Cytokine 12:477-482. 109. Watanabe-Fukunaga R, Brannan CI, Copeland NG, et al. (1992) Lymphoproliferation disorder in mice explained by...defects in Fas antigen that mediates apoptosis. Nature 356(6367):314-317. 110. Serreze DV, Bridgett M, Chapman HD, et al. (1998) Subcongenic analysis of the... | |
| Shu Q. Liu - 2007 - 800 páginas
...factor, Nature Med 8:349-57, 2002. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by...defects in Fas antigen that mediates apoptosis, Nature 356:314-17, 1992. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, et al: The cDNA... | |
| |